Processa Pharmaceuticals, Inc.
PCSA • NASDAQ
Processa Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO George K. Ng, with a market cap of $7.4M.
Market Cap$7.4M
Employees13.0
CEOGeorge K. Ng
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksAfter Market Close · Q1 2026
Financials
Processa Pharmaceuticals, Inc. FAQ
Common questions about Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026 after market close.
Processa Pharmaceuticals, Inc. has approximately 13 employees.